Institutional investors’ sustainability policies and the outcomes for the healthcare sector portfolios
Author
Abstract
Suggested Citation
DOI: 10.1016/j.healthpol.2021.05.015
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Gunnar Friede & Timo Busch & Alexander Bassen, 2015. "ESG and financial performance: aggregated evidence from more than 2000 empirical studies," Journal of Sustainable Finance & Investment, Taylor & Francis Journals, vol. 5(4), pages 210-233, October.
- Marco Becht & Julian Franks & Jeremy Grant & Hannes F. Wagner, 2017.
"Returns to Hedge Fund Activism: An International Study,"
The Review of Financial Studies, Society for Financial Studies, vol. 30(9), pages 2933-2971.
- Franks, Julian & Becht, Marco & Wagner, Hannes & Grant, Jeremy, 2015. "The Returns to Hedge Fund Activism: An International Study," CEPR Discussion Papers 10507, C.E.P.R. Discussion Papers.
- Javier Gil‐Bazo & Pablo Ruiz‐Verdú, 2009. "The Relation between Price and Performance in the Mutual Fund Industry," Journal of Finance, American Finance Association, vol. 64(5), pages 2153-2183, October.
- Kevin M. Murphy & Robert H. Topel, 2006.
"The Value of Health and Longevity,"
Journal of Political Economy, University of Chicago Press, vol. 114(5), pages 871-904, October.
- Kevin M. Murphy & Robert H. Topel, 2005. "The Value of Health and Longevity," NBER Working Papers 11405, National Bureau of Economic Research, Inc.
- Joseph E. Stiglitz, 2016. "How to Restore Equitable and Sustainable Economic Growth in the United States," American Economic Review, American Economic Association, vol. 106(5), pages 43-47, May.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Marie-Louise Leroux & Pierre Pestieau & Grégory Ponthière, 2008.
"Should we subsidize longevity?,"
Working Papers
halshs-00586236, HAL.
- Marie-Louise Leroux & Pierre Pestieau & Grégory Ponthière, 2008. "Should we subsidize longevity?," PSE Working Papers halshs-00586236, HAL.
- LEROUX, Marie-Louise & PESTIEAU, Pierre & PONTHIÈRE, Grégory, 2008. "Should we subsidize longevity?," LIDAM Discussion Papers CORE 2008058, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
- Marie-Louise Leroux & Pierre Pestieau & Grégory Ponthiere, 2009. "Should we Subsidize Longevity?," CESifo Working Paper Series 2614, CESifo.
- Choi, Gahyun & Park, Kwangyeol & Yi, Eojin & Ahn, Kwangwon, 2023. "Price fairness: Clean energy stocks and the overall market," Chaos, Solitons & Fractals, Elsevier, vol. 168(C).
- Christos A Makridis & Andrew A Borkowski & Gil Alterovitz, 2024. "Perspectives on advancing innovation and human flourishing through a network of AI institutes," Science and Public Policy, Oxford University Press, vol. 51(3), pages 557-562.
- Willem Schramade, 2016. "Integrating ESG into valuation models and investment decisions: the value-driver adjustment approach," Journal of Sustainable Finance & Investment, Taylor & Francis Journals, vol. 6(2), pages 95-111, April.
- Kai Hong & Peter A. Savelyev & Kegon T. K. Tan, 2020.
"Understanding the Mechanisms Linking College Education with Longevity,"
Journal of Human Capital, University of Chicago Press, vol. 14(3), pages 371-400.
- Hong, Kai & Savelyev, Peter A. & Tan, Kegon T.K., 2020. "Understanding the Mechanisms Linking College Education with Longevity," IZA Discussion Papers 13118, Institute of Labor Economics (IZA).
- Kai Hong & Peter Savelyev & Kegon Teng Kok Tan, 2020. "Understanding the Mechanisms Linking College Education with Longevity," Working Papers 2020-022, Human Capital and Economic Opportunity Working Group.
- Scott, Andrew J., 2023. "The economics of longevity – An introduction," The Journal of the Economics of Ageing, Elsevier, vol. 24(C).
- K. Thomas Liaw, 2020. "Survey of Green Bond Pricing and Investment Performance," JRFM, MDPI, vol. 13(9), pages 1-12, August.
- Zhang, Dongyang, 2023. "Does green finance really inhibit extreme hypocritical ESG risk? A greenwashing perspective exploration," Energy Economics, Elsevier, vol. 121(C).
- Al-Shaer, Habiba & Uyar, Ali & Kuzey, Cemil & Karaman, Abdullah S., 2023. "Do shareholders punish or reward excessive CSR engagement? Moderating effect of cash flow and firm growth," International Review of Financial Analysis, Elsevier, vol. 88(C).
- Lang, Gunnar, 2011. "Auswirkungen der Finanzmarktintegration auf Investmentfondsgebühren in der EU," ZEW Wachstums- und Konjunkturanalysen, ZEW - Leibniz Centre for European Economic Research, vol. 14(4), pages 10-11.
- Simon Dikau & Nick Robins & Matthias Täger, 2019. "Building a sustainable financial system: the state of practice and future priorities," Financial Stability Review, Banco de España, issue Autumn.
- Wong, Woei Chyuan & Batten, Jonathan A. & Ahmad, Abd Halim & Mohamed-Arshad, Shamsul Bahrain & Nordin, Sabariah & Adzis, Azira Abdul, 2021. "Does ESG certification add firm value?," Finance Research Letters, Elsevier, vol. 39(C).
- Tomas J. Philipson & Eric Sun, 2008.
"Is the Food And Drug Administration Safe And Effective?,"
Journal of Economic Perspectives, American Economic Association, vol. 22(1), pages 85-102, Winter.
- Tomas J. Philipson & Eric Sun, 2007. "Is the Food and Drug Administration Safe and Effective?," NBER Working Papers 13561, National Bureau of Economic Research, Inc.
- Philipson, Tomas J. & Sun, Eric, 2007. "Is the Food and Drug Administration Safe and Effective?," Working Papers 218, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.
- Danny Zhao‐Xiang Huang, 2022. "An integrated theory of the firm approach to environmental, social and governance performance," Accounting and Finance, Accounting and Finance Association of Australia and New Zealand, vol. 62(S1), pages 1567-1598, April.
- Ana C. DÃaz†Mendoza & Germán López†Espinosa & Miguel A. MartÃnez, 2014. "The Efficiency of Performance†Based Fee Funds," European Financial Management, European Financial Management Association, vol. 20(4), pages 825-855, September.
- Hideaki Miyajima & Ryo Ogawa & Takuji Saito, 2016. "Changes in the Corporate Governance System and Presidential Turnover," Working Papers halshs-01680409, HAL.
- Lakdawalla, Darius N. & Seabury, Seth A., 2012.
"The welfare effects of medical malpractice liability,"
International Review of Law and Economics, Elsevier, vol. 32(4), pages 356-369.
- Darius N. Lakdawalla & Seth A. Seabury, 2009. "The Welfare Effects of Medical Malpractice Liability," NBER Working Papers 15383, National Bureau of Economic Research, Inc.
- Andreas G. F. Hoepner & Lisa Schopohl, 2020. "State Pension Funds and Corporate Social Responsibility: Do Beneficiaries’ Political Values Influence Funds’ Investment Decisions?," Journal of Business Ethics, Springer, vol. 165(3), pages 489-516, September.
- Jerzmanowski, Michal & Tamura, Robert, 2019.
"Directed technological change & cross-country income differences: A quantitative analysis,"
Journal of Development Economics, Elsevier, vol. 141(C).
- Jerzmanowski, Michal & Tamura, Robert, 2017. "Directed Technological Change & Cross Country Income Differences: A Quantitative Analysis," MPRA Paper 80582, University Library of Munich, Germany.
- Jerzmanowski, Michal & Tamura, Robert, 2017. "Directed Technological Change & Cross Country Income Differences: A Quantitative Analysis," MPRA Paper 100809, University Library of Munich, Germany.
- Strulik, Holger, 2018.
"The return to education in terms of wealth and health,"
The Journal of the Economics of Ageing, Elsevier, vol. 12(C), pages 1-14.
- Strulik, Holger, 2016. "The return to education in terms of wealth and health," University of Göttingen Working Papers in Economics 293, University of Goettingen, Department of Economics.
More about this item
Keywords
Drug development; R&D finance; Institutional investors; Clinical value added;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:125:y:2021:i:10:p:1367-1376. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.